Biophytis (France) Executives
| ALBPS Stock | EUR 0.30 0.01 3.45% |
Biophytis employs about 26 people. The company is managed by 8 executives with a total tenure of roughly 29 years, averaging almost 3.0 years of service per executive, having 3.25 employees per reported executive. Discussion of Biophytis' management performance can provide insight into the enterprise performance.
| Stanislas Veillet Chairman Chairman of the Board, CEO |
Biophytis |
Biophytis Management Team Effectiveness
The company has return on total asset (ROA) of (0.5067) % which means that it has lost $0.5067 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.8078) %, meaning that it generated substantial loss on money invested by shareholders. Biophytis' management efficiency ratios could be used to measure how well Biophytis manages its routine affairs as well as how well it operates its assets and liabilities.Biophytis Workforce Comparison
Biophytis SA is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 585. Biophytis holds roughly 26.0 in number of employees claiming about 4% of equities under Health Care industry.
Biophytis SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biophytis SA Price Series Summation is a cross summation of Biophytis price series and its benchmark/peer.
Biophytis Notable Stakeholders
A Biophytis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biophytis often face trade-offs trying to please all of them. Biophytis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biophytis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stanislas Veillet | Chairman of the Board, CEO | Profile | |
| Waly Dioh | Director of Research & Development | Profile | |
| Pierre Dilda | Director of Research | Profile | |
| Rene Lafont | Scientific Director | Profile | |
| Philippe Rousseau | Chief Officer | Profile | |
| Benoit Canolle | Chief Officer | Profile | |
| Teylan | Financial Controller | Profile | |
| FFPM MBA | Chief Officer | Profile |
About Biophytis Management Performance
The success or failure of an entity such as Biophytis SA often depends on how effective the management is. Biophytis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biophytis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biophytis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was founded in 2006 and is headquartered in Paris, France. BIOPHYTIS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 30 people.
Biophytis Workforce Analysis
Traditionally, organizations such as Biophytis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biophytis within its industry.Biophytis Manpower Efficiency
Return on Biophytis Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.2M | |
| Net Loss Per Executive | 3.9M |
Additional Tools for Biophytis Stock Analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.